Ex vivo interrogation of the genetic and biochemical networks controlling influe
Ex vivo interrogation of the genetic and biochemical networks controlling influe
批准号:
9282679
负责人:
Megan Louise Shaw
金额:
$120.52万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressBindingBiochemicalCellsChIP-seqChemicalsClinicalCollaborationsComplementary DNAComplexComputer SimulationDNA-Directed RNA PolymeraseDataData CollectionDevelopmentDiseaseEpigenetic ProcessEpithelial CellsEventGenerationsGenesGeneticGlobal ChangeHumanImmune responseInfectionInfluenzaInfluenza A virusInstructionIntegration Host FactorsKnowledgeLife Cycle StagesLungMeasuresModelingMolecularOutcomePathogenicityPharmacologyPhenotypePlayPopulationPost-Translational Protein ProcessingPredispositionProteinsProteomeRNARNA InterferenceResolutionRoleSeriesStudy modelsSurveysSystemSystems BiologyTechnologyTimeValidationViralViral InterferenceViral PathogenesisVirusVirus DiseasesVirus Replicationclinical efficacydata modelingepigenomeepigenomicsextracellularfunctional genomicsgenetic analysisgenome-wideglobal run on sequencingin vivoinfluenzavirusinterestmacrophagemetabolomemetabolomicsmonocytenetwork modelsnext generation sequencingnovel therapeuticspathogenpredictive modelingpromoterrespiratoryresponsescreeningtherapeutic targettranscriptometranscriptome sequencingtranscriptomicsvalidation studiesvirus host interaction
中文摘要
项目总结(见说明);本申请的基本假设是宿主-病原体相互作用和反应的关键分子特征决定了病毒感染的致病结果。因此,全面了解病毒-宿主相互作用、对病毒感染的先天反应和病毒逃避策略对于病毒发病机制的预测建模至关重要。在这里,我们将提供一个全面的概述遗传,化学和生物化学网络,在控制流感病毒感染中发挥作用,通过研究宿主-病毒的相互作用,在体外设置使用原代人类细胞。将使用下一代测序技术研究流感病毒复制对宿主的影响,以询问细胞RNA群体以确定转录组水平变化(RNA-seq),对RNA聚合酶参与的启动子进行全基因组调查(GRO-seq),以及评估染色体景观中的表观遗传改变(CHiP-seq)。此外,将测量细胞内和细胞外代谢物水平、蛋白质丰度以及病毒感染后诱导的翻译后修饰的总体变化。将这些方法与全基因组功能基因组筛选和高通量蛋白质相互作用组分析相结合,将能够生成精确描述流感病毒与宿主之间相互作用层次的高分辨率网络。通过对三种驱动不同致病结果的病毒同时进行这些分析,这些数据的计算建模将使我们能够识别预测病毒发病机制的病毒-宿主网络的关键节点。这些节点的体内和临床影响将分别在项目2和3中进行评价。
英文摘要
PROJECT SUMMARY (See instructions); The underlying hypothesis of this application is that critical molecular features of host-pathogen interactions and responses dictate the pathogenic outcome of viral infection. Thus, a comprehensive understanding of viral-host interactions, innate responses to viral infection, and viral evasion strategies is pivotal for predictive modeling of viral pathogenesis. Here, we will provide a comprehensive overview ofthe genetic, chemical, and biochemical networks that play a role in controlling influenza virus infection by investigating host-virus interactions in an ex vivo setting using primary human cells. The impact of influenza virus replication on the host will be studied using next generation sequencing technologies to interrogate cellular RNA populations to define transcriptome-level changes (RNA-seq), conduct genome-wide survey of promoters engaged by RNA polymerase (GRO-seq), as well as evaluate epigenetic alterations in the chromosomal landscape (CHiP-seq). Furthermore, global alterations in intracellular and extracellular metabolite levels, protein abundance, as well as post-translational modifications induced upon viral infection will be measured. Combining these approaches with genome-wide functional genomic screening and high-throughput protein interactome analysis will enable the generation of high-resolution networks that accurately depict the hierarchies of interactions between influenza virus and the host. By conducting these analyses simultaneously with three viruses that drive varying pathogenic outcomes, computational modeling of these data will enable us to identify critical nodes ofthe viral-host network that are predictive of viral pathogenesis. The in vivo and clinical impact of these nodes will be evaluated in Projects 2 and 3, respectively.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery of influenza virus polymerase inhibitors
-
批准号:9427969
-
项目类别:
-
资助金额:$16.92万
-
财政年份:2017
-
负责人:Megan Louise Shaw
-
依托单位:
Host-targeted antivirals for influenza and other respiratory virus infections
-
批准号:8390073
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2012
-
负责人:Megan Louise Shaw
-
依托单位:
A high-throughput screen for antivirals targeting filovirus replication
-
批准号:8340649
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2012
-
负责人:Megan Louise Shaw
-
依托单位:
A high-throughput screen for antivirals targeting filovirus replication
-
批准号:8695285
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2012
-
负责人:Megan Louise Shaw
-
依托单位:
A high-throughput screen for antivirals targeting filovirus replication
-
批准号:8519295
-
项目类别:
-
资助金额:$39.83万
-
财政年份:2012
-
负责人:Megan Louise Shaw
-
依托单位:
Host-targeted antivirals for influenza and other respiratory virus infections
-
批准号:8495266
-
项目类别:
-
资助金额:$25.14万
-
财政年份:2012
-
负责人:Megan Louise Shaw
-
依托单位:
INHIBITION OF INFLUENZA VIRUS NS1 FUNCTION BY SMALL MOLECULES
-
批准号:7860476
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2009
-
负责人:Megan Louise Shaw
-
依托单位:
INHIBITION OF INFLUENZA VIRUS NS1 FUNCTION BY SMALL MOLECULES
-
批准号:7700497
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2009
-
负责人:Megan Louise Shaw
-
依托单位:
Ex vivo interrogation of the genetic and biochemical networks controlling influe
-
批准号:8689901
-
项目类别:
-
资助金额:$79.87万
-
财政年份:--
-
负责人:Megan Louise Shaw
-
依托单位:
Ex vivo interrogation of the genetic and biochemical networks controlling influe
-
批准号:8580808
-
项目类别:
-
资助金额:$78.57万
-
财政年份:--
-
负责人:Megan Louise Shaw
-
依托单位:
Ex vivo interrogation of the genetic and biochemical networks controlling influe
-
批准号:8852055
-
项目类别:
-
资助金额:$87.09万
-
财政年份:--
-
负责人:Megan Louise Shaw
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: